ASND Competitors & Alternatives
Compare Ascendis Pharma AS with similar stocks in the same industry
Biotechnology
ASND
Main Stock$230.83
Tradestie Score
56
Market Cap
$12.36B
P/E Ratio
26.7
Revenue Growth
1.4%
Analyst Upside
+27.0%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GMAB
Genmab A/S ADS
|
$25.27
|
$19.56B | 19.4 | 54 | Compare |
|
INCY
Incyte Genomics Inc
|
$98.22
|
$16.93B | 14.0 | 54 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$52.96
|
$15.70B | 28.3 | 52 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$13.75
|
$15.22B | - | 52 | Compare |
|
EXEL
Exelixis Inc
|
$51.91
|
$11.09B | 17.4 | 58 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$31.43
|
$10.76B | - | 66 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$63.96
|
$10.74B | - | 58 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$54.69
|
$10.53B | 39.6 | 57 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$74.12
|
$10.49B | - | 56 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$66.27
|
$10.22B | - | 60 | Compare |
More ASND Analysis
Data updated: Jun 18, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry